Loss of carbohydrate sulfotransferase 6 function leads to macular corneal dystrophy phenotypes and skeletal defects in zebrafish
The FEBS Journal · 2025
DOI: 10.1111/febs.17337 ↗Kurz gefasst
Fachartikel in der Zeitschrift The FEBS Journal, 2025. Verfasst von Merve Basol und 5 weiteren Autor:innen. Beteiligte Einrichtung: Izmir Biomedicine and Genome Center, Turkey. Hauptthemen laut MEDLINE: Zebrafish, Sulfotransferases, Zebrafish Proteins, Corneal Dystrophies, Hereditary. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Türkiye Bilimsel ve Teknolojik Araştırma Kurumu.
Abstract (Originalsprache)
The carbohydrate sulfotransferase 6 ( chst6 ) gene is linked to macular corneal dystrophy (MCD), a rare disease that leads to bilateral blindness due to the accumulation of opaque aggregates in the corneal stroma. chst6 encodes for a keratan sulfate proteoglycan (KSPG) specific sulfotransferase. MCD patients lose sulfated KSPGs (cKS) in the cornea and the serum. The significance of serum cKS loss has not been understood. Zebrafish cornea structure is similar to that of humans and it contains high levels of sulfated cKS in the stroma. Here, zebrafish chst6 is shown to be expressed in the cornea and head structures of the embryos. An animal model of MCD is developed by generating chst6 mutant animals with CRISPR/Cas9‐mediated gene editing. The dramatic decrease in cKS epitopes in the mutants was shown with ELISA and immunofluorescence. Morphological defects or alterations of jaw cartilage were detected in a minor fraction of the mutant larvae. Loss of cKS epitopes and morphological defects was fully rescued with wild‐type chst6 . Mutant adult zebrafish displayed all clinical manifestations of MCD, while a fraction also displayed jaw and skeleton defects. Opaque accumulations formed in the eye, which were alcian blue positive. Loss of cKS in the corneal stroma and a decrease in corneal thickness were shown. Interestingly, alteration of transforming growth factor beta‐induced (BIGH3) expression which was not described in patients was also observed. This is the first report of an MCD model in a genetically tractable organism, providing a preclinical model and insight into the importance of KSPG sulfation for proper skeletal morphogenesis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Izmir Biomedicine and Genome Center, Turkey.
- Izmir International Biomedicine and Genome Institute, Dokuz Eylül University, Izmir, Turkey.
- Department of Ophthalmology, Faculty of Medicine, Dokuz Eylul University, Izmir, Turkey.
- Department of Medical Biology, Faculty of Medicine, Dokuz Eylül University, Izmir, Turkey.
ORCID-Profile: Sibel Kalyoncu, Gulcin Cakan-Akdogan
Förderung
- Türkiye Bilimsel ve Teknolojik Araştırma Kurumu
Zitieren
APA
Basol, M., Ersoz-Gulseven, E., Ozaktas, H., Kalyoncu, S., Utine, C. A., & Cakan-Akdogan, G. (2025). Loss of carbohydrate sulfotransferase 6 function leads to macular corneal dystrophy phenotypes and skeletal defects in zebrafish. The FEBS Journal. https://doi.org/10.1111/febs.17337
Vancouver
Basol M, Ersoz-Gulseven E, Ozaktas H, Kalyoncu S, Utine CA, Cakan-Akdogan G. Loss of carbohydrate sulfotransferase 6 function leads to macular corneal dystrophy phenotypes and skeletal defects in zebrafish. The FEBS Journal. 2025. doi:10.1111/febs.17337
BibTeX
@article{Basol2025,
author = {Basol, Merve and Ersoz-Gulseven, Esra and Ozaktas, Helin and Kalyoncu, Sibel and Utine, Canan Asli and Cakan-Akdogan, Gulcin},
title = {Loss of carbohydrate sulfotransferase 6 function leads to macular corneal dystrophy phenotypes and skeletal defects in zebrafish},
journal = {The FEBS Journal},
year = {2025},
doi = {10.1111/febs.17337}
}
EUVIMED